Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Acrux Limited (ARUXF)
OTHER OTC:ARUXF
Holding ARUXF?
Track your performance easily
ARUXF Stock Chart & Stats
Day’s Range$0 - $0
52-Week Range$0.02 - $0.08
Previous Close$0.03
Volume500.00
Average Volume (3M)2.23K
Market Cap
$8.46M
Enterprise Value$6.01M
Total Cash (Recent Filing)AU$5.83M
Total Debt (Recent Filing)AU$2.08M
Price to Earnings (P/E)―
Beta0.54
Next Earnings
Feb 20, 2025EPS EstimateN/A
Last Dividend Ex-Date
Aug 18, 2015Dividend YieldN/A
Share Statistics
EPS (TTM)-0.01
Shares OutstandingN/A
10 Day Avg. Volume0
30 Day Avg. Volume2,233
Standard Deviation0.25
R-Squared0.02
Alpha-0.02
Financial Highlights & Ratios
Price to Book (P/B)0.00
Price to Sales (P/S)9.25
Price to Cash Flow (P/CF)N/A
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
Acrux Limited News
PremiumCompany Announcements
Acrux Limited Highlights Growth and Partnerships
PremiumCompany Announcements
Acrux Limited Eyes Revenue Growth with New Product Launches
PremiumCompany Announcements
Acrux Limited Announces 2024 AGM for Shareholders
PremiumCompany Announcements
Acrux Limited Spotlights at ASX ConferencePremiumCompany Announcements
Acrux Limited Announces FY24 Results Webinar
PremiumCompany Announcements
Acrux Limited Cautions on Future ProjectionsPremiumCompany Announcements
Acrux Limited Publishes Annual Governance ReportsPremiumCompany Announcements
Acrux Limited Faces Revenue Decline and LossesOptions Prices
Currently, No data available
---
Ownership Overview
ARUXF FAQ
What was Acrux Limited’s price range in the past 12 months?
Acrux Limited lowest stock price was $0.02 and its highest was $0.08 in the past 12 months.
What is Acrux Limited’s market cap?
Currently, no data Available
When is Acrux Limited’s upcoming earnings report date?
Acrux Limited’s upcoming earnings report date is Feb 20, 2025 which is in 86 days.
How were Acrux Limited’s earnings last quarter?
Acrux Limited released its earnings results on Aug 28, 2024. The company reported -$0.006 earnings per share for the quarter, missing the consensus estimate of N/A by -$0.006.
Is Acrux Limited overvalued?
According to Wall Street analysts Acrux Limited’s price is currently Overvalued.
Does Acrux Limited pay dividends?
Acrux Limited pays a Notavailable dividend of $0.04 which represents an annual dividend yield of N/A. See more information on Acrux Limited dividends here
What is Acrux Limited’s EPS estimate?
Acrux Limited’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Acrux Limited have?
Acrux Limited has 290,716,860 shares outstanding.
What happened to Acrux Limited’s price movement after its last earnings report?
Acrux Limited reported an EPS of -$0.006 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went same 0%.
Which hedge fund is a major shareholder of Acrux Limited?
Currently, no hedge funds are holding shares in ARUXF
---
Acrux Limited Stock Smart Score
Unlock Smart Score
1
2
3
4
5
6
7
8
9
10
Blogger Sentiment
Bullish
ARUXF Sentiment 71%
Sector Average 72%
Sector Average 72%
News Sentiment
Neutral
Bullish news 50%
Bearish news 50%
Bearish news 50%
Technicals
SMA
Negative
20 days / 200 days
Momentum
-14.28%
12-Months-Change
Fundamentals
Return on Equity
-95.25%
Trailing 12-Months
Asset Growth
-30.16%
Trailing 12-Months
Company Description
Acrux Limited
Acrux Ltd is an Australian pharmaceutical company dedicated to developing and commercializing generic transdermal and topical prescription pharmaceuticals. It has developed and commercialized, through licensees, several pharmaceutical products in the US, Europe, and other markets. Its products include Testosterone Solution, Estradiol MDTS. It also has some of its products under pipeline.
---
Technical Analysis
---